Iovance Biotherapeutics Inc ASCO Abstracts Conference Call Transcript
Good afternoon, and welcome to the Iovance Biotherapeutics Clinical Development Program Update Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
Now I would like to turn the conference over to Tim Morris, Chief Financial Officer at Iovance. Sir, please go ahead.
Thank you, operator. Good morning, everyone, and thank you for joining us today. With me on the call is Maria Fardis, President and CEO.
I'd like to remind everyone that statements made during this conference call will include forward-looking statements regarding Iovance's goals; business focus; business plans; clinical trial, plans and results; potential future applications of our technology; manufacturing capabilities; regulatory feedback and guidance; licensing and collaboration agreements; and future updates. Forward-looking statements are subject to numerous risk and uncertainties, many of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
